Browser storage is unavailable. Keep this page open and export your collection before leaving.
Sourced product detail plus founders, customers, workflow, pricing, origins or business model.
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for clinical trials and predict disease progression.
Customers · Founders · Product · How it works
abinitio bio is the AI-native operating platform for drug development and manufacturing.
Founders · Product · How it works
Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug…
Founders · Product · How it works
Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for greater safety and efficacy.
Founders · Product · How it works
We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'…
Founders · Product · How it works
Spatial proteomics from H&E and multimodal patient data imputation. Lattice predicts spatially resolved protein-marker maps from routine H&E slides as virtual multiplex immunofluorescence (mIF) channels, transforming incomplete patient…
Founders · Product · How it works
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents. Sourcing Agent: Mines public/private databases and unstructured global data to…
Founders · Origins · Product
We are developing therapies for disorders driven by dysfunctional neural circuits. To develop these therapies, we are building an agentic discovery platform that learns from experiments in our own in vivo lab. Our agents use…
Founders · Product · How it works
A clinical-stage neuroscience biotech developing innovative new chemical entities that transform the treatment paradigm of psychiatric disease.
Founders · Product
Nanograb is building the future of AI-powered targeted gene delivery.
Founders · Product
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After…
Founders · Product
Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary…
Founders · Product
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more…
Founders · Product
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the…
Founders · Product
Explore Matrubials, Inc. - a leader in milk-inspired therapeutics and innovative solutions for women's health, including bacterial vaginosis treatments.
Founders · Product
BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside…
Founders · Product
GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. We develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. Our team is…
Product · How it works
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling…
Founders · Product
Diffuse is building generative AI for protein design. Our mission is to build AI systems that engineer new and useful proteins with unprecedented control and accuracy. Our team has been behind breakthroughs in AI protein design for the…
Founders · Product
Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA
Founders · Product
Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control…
Founders · Product
What if we made as many cancer drugs next year as we have in the last decade?
Founders · Product
